Sheridan William P's Form 4 filing
Biocryst Pharmaceuticals Inc (BCRX) · filed Mar 14, 2022
- Accession no.
- 0001127602-22-009124
- Filed
- Mar 14, 2022
- Trade date
- Mar 10, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.72M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sheridan William PCIK 0001439174 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Common Stock | MOption exerciseAcquired | +148,302 | $3.22 | +$477,532.44 | 199,093 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −159,739 | $16.87 | −$2,694,796.93 | 39,354 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −1,400 | $17.64 | −$24,696 | 37,954 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Common Stock | MOption exerciseDisposed | −148,302 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.